LTS Receives Best Managed Companies Award 2025
LTS has been honored with the Best Managed Companies Award 2025, joining the ranks of Germany’s top excellently managed businesses this year.
Recognized with a prestigious award and seal of excellence, LTS was selected for its outstanding performance in Strategy, Productivity & Innovation, Culture & Commitment, and Governance & Finance.
This award marks a significant milestone in the company’s journey and is a testament to the dedication of all LTS employees.
With competence, experience, and innovative spirit, they advance the company’s mission every day: delivering top-quality products to partners to improve the lives of patients. Driven by its purpose — We CARE. We CREATE. We DELIVER. — and a clear vision for the future, LTS continuously invests in research, sustainable processes, and the evolution of its corporate culture.
For 40 years, LTS has stood for pioneering spirit and innovation in the development and manufacturing of alternative drug delivery systems.
The success story began with the introduction of transdermal patches and has since expanded to include oral thin films, microneedle patches, and wearable devices.
The mission has always been the same: to enable better and more convenient medication for patients through advanced technologies. As one of the leading pharmaceutical CDMOs, LTS remains committed to evolving its technologies and setting new standards in quality and patient comfort.
